Events Archives - Page 18 of 128

1 minute read

TScan Therapeutics To Host Virtual KOL Event To Discuss Results From Ongoing Phase 1 Trial Of TSC-100 And TSC-101 Presented At The 65th ASH Annual Meeting And Exposition

December 4, 5:22 PM

TScan Therapeutics, Inc. (NASDAQ:TCRX), a clinical-stage biopharmaceutical company focused on the development of T cell receptor (TCR)-engineered T cell therapies (TCR-T) for the treatment of patients with cancer, today

TCRX

2 minute read

Man Planned On ‘Killing People’ During Tesla’s Cybertruck Event: ‘Up To You Guys To Stop Me’

By Adam Eckert

December 4, 5:01 PM

Tesla Inc's (NASDAQ: TSLA) long-awaited Cybertruck delivery event took place last week.

Al Jaber Controversy At COP28: Event’s President Says ‘No Science’ Comments Misrepresented

By Neil Dennis

December 4, 10:55 AM

Global oil prices fell on Monday after COP28 president Sultan Al Jaber hit back at criticisms of comments he made before the climate summit.

COP

2 minute read

AMD Exec Forrest Norrod Expects AI Revenue To Exceed $2B In 2024 Thanks To MI300

By Surbhi Jain

December 4, 10:12 AM

On the AI front, Norrod expects extraordinary interest levels over the next 24 months, with AMD's MI300 revenue exceeding $2 billion in 2024.

AMD

1 minute read

BetMGM Business Update; Delivery Of 2023 Guidance, Reaching The Upper End Of $1.8B-$2B Revenue And Achieving EBITDA Profitability In The Second Half; Setting A Target Of Approximately $500M EBITDA In 2026 For BetMGM

By Benzinga Newsdesk

December 4, 10:08 AM

Business on Track with Key Enhancements to Drive Sustainable GrowthLAS VEGAS, Dec. 4, 2023 /PRNewswire/ -- BetMGM, LLC ("BetMGM"), one of the leading sports betting and iGaming operators across the U.S., jointly owned by

MGM

2 minute read

EXCLUSIVE: Tema ETFs’ Innovative Thematic Investing Approach Targets New Opportunities Beyond The Fads

By Piero Cingari

December 1, 12:14 PM

Tema ETFs is redefining thematic investing, focusing on long-term structural trends & precision in security selection rather than chasing short-term fads.

CANC

2 minute read

Stoke Therapeutics Presents Data From Multiple Studies Of Children And Adolescents With Dravet Syndrome At The American Epilepsy Society 2023 Annual Meeting

By Benzinga Newsdesk

December 1, 10:06 AM

– Data from clinical studies of STK-001 demonstrated clinical benefit for patients ages 2 to 18 years old, including reductions in seizures and improvements in cognition and behavior that support the potential for

STOK

2 minute read

Events
News

Navitas Showcases High-power Semiconductors For EV, Solar & Industrial At Next-Gen Munich Conference

By Benzinga Newsdesk

December 1, 9:32 AM

Navitas Semiconductor (NASDAQ:NVTS), the industry leader in next-generation GaNFast™ gallium nitride (GaN) and GeneSiC™ silicon carbide (SiC) power semiconductors, announced today its participation in and

NVTS

4 minute read

BiomX To Host Virtual Key Opinion Leader Event To Review The Results From Part 2 Of Phase 1b/2a Trial Of BX004 In Cystic Fibrosis Patients With Chronic Pseudomonas aeruginosa Infections On December 4, 2023

By Benzinga Newsdesk

November 30, 5:29 PM

BiomX Inc. (NYSE:PHGE) ("BiomX" or the "Company"), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today announced it will host a virtual KOL

PHGE

6 minute read

Exact Sciences Presents Multiple Studies At San Antonio Breast Cancer Symposium Supporting Optimization And Individualization Of Therapy For Breast Cancer Patients

By Benzinga Newsdesk

November 30, 5:25 PM

Updated TAILORx follow-up data showing the integration of clinico-pathologic criteria and Recurrence Score® results to refine distant recurrence risk estimatesNew concordance analysis supporting the generation of

EXAS